SlideShare a Scribd company logo
1 of 9
Sweet Sensors
Small form factor                                                                  Types of targets
diagnostic devices that
can detect a variety of                                                            •   Recreational drugs
biological markers.                                                                •   Heavy metals
                                                                                   •   Toxins
• Inexpensive                                                                      •   Bacteria
• Quantitative                                                                     •   Viruses
• Adaptable to many                                                                •   Pharmaceuticals
  kinds of tests (targets)                                                         •   Environmental hazards
                                                                                   •   Food safety targets




                             Yu Xiang and Yi Lu, Nature Chem. 3, 697-703 (2011).
Meetings/Conversations From the Past Week
• Tecan group
   – Global provider of laboratory instruments and
     solutions in biopharmaceuticals, forensics, and
     clinical diagnostics.
• Teleconference with Director
  of Strategic Alliances and three of her associates
  in a major pharmaceutical company
• Abbott
• Director of Economic & Technical Development
  Zone, Shanghai China
• Food Safety and Quality Conference
• Dr. Bill Olson, Market Medical Director - Pacific
  Region United Healthcare
Upcoming Conversations

• Sword Diagnostics
• Abbott Labs
• Blue Cross Blue Shield innovation team
• Retired Hospital executive
• Biotech entrepreneur
• Michael Rosen, life sciences entrepreneur
  and executive
• Other VCs
Key findings:
• Big pharma company is interested in low cost
  drug monitoring during clinical trials and after the
  drugs are approved to ensure safety and
  effectiveness of the drug to individual patients
   – Site visit in December
• Work with glucose meter manufacturers
   – Our technology makes a particular glucose meter
     more competitive on the market
• Look for biomarkers for diseases that associated
  with diabetes
• Invitation to give a presentation @Abbott in
  December
• Emergency room, rapid toxicology screen
Business Model Canvas # 8
                                                                                     Yi Lu, Tian Lan, Brian Wong
                                                 Sweet Sensors                       Neil Kane                     11-15-2011
                                                                                     Chris Sorensen



                        Conferences

                        R&D
Pharmaceutical                                   Immediate results                                       Pharmaceutical
companies               Publicity                                                                        companies
                                                                            Direct
                                                Convenient monitoring
Diagnostics             Insurance Reimbursement and safer dosage            Long term
companies                                                                                                Diagnostic
                                                Robust/extensible                                        companies
Contract research
organizations
                                                 Inexpensive                                              Contract research
                                                                                                          organizations
                                                 Simple                     Pharmaceutical Cos
                          IP        Investors

Glucometer mfr           Personnel

                         Pharmaceutical Cos
Strip mfr




            Licensing                                          Licensing?

            R&D                                                Product Sales
Partners
 • As noted on the Business Model Canvas, key
   partners are pharmaceutical companies and
   glucose meter manufacturers.

                      Sweet Sensors
Glucose meter                                   Pharmaceutical /
manufacturer          • Added value for meter   diagnostic companies
• Meter engineering     manufacturers           • Provide the target of
• Strip design        • Low cost, fast             interest
• FDA approval          monitoring improves     • Key customers
                        clinical trials         • Key market knowledge
Action plan
• Put together a compelling
  presentation and go pitch
  pharmaceutical
  companies and diagnostic
  companies. We’re getting
  inconclusive results talking
  to KOLs and consultants.
• We are on second revision
  of a pitch to use.
Sweet Sensor Revenue Model

                                                             Factors
                             COPD MARKET                               All Segments
                             Market Size                                    16,000,000


   Revenue Model
                             Market Share Target                                  10%
                             Channel Capacity                                    100%
                             Customer Activations                           1,600,000
                             Attrition                                            10%
                             Net Customers                                   1,440,000

          Missing:           Revenue Model
                             Usage per Year                                        52

Lifetime value of customer   Number of Uses per Year
                             Revenue per Use                      $4
                                                                          74,880,000
                                                                                  $4

and amortization of          Total revenue                              $299,520,000


acquisition costs over       EXPENSES

                             Cost Per Customer Acquisition       $25             $25

lifetime                     Cust. Acquisiiton Expense                   $40,000,000

                             Channel Split                       30%             30%
                             Cost of Channel Sales                        $89,856,000

                             COGS                              $0.25      $18,720,000


                             Net Operating Income                       $150,944,000
                             Operating Margin                                   50%

                             Operating Expenses
                             GSA                                          $5,000,000


                             EBIDTA                                     $145,944,000
                             Net Margin                                   49%
Service Channel Distribution Model
                               Payment
                Insurance                      Doctor
                Company

                                                    Medical
      Payment                                       Services
                                   Data
                                   Service

            Service Provider                   Patient
             “Healthways”
                               In House Care
                                  Services
       Payment



                  Sweet
                 Sensors

More Related Content

What's hot

Red Brand Canners
Red Brand CannersRed Brand Canners
Red Brand Canners
jindalm
 
Final hubspot presentation
Final hubspot presentationFinal hubspot presentation
Final hubspot presentation
anushagovindan
 
Heineken n-v-global-branding-and-advertising
Heineken n-v-global-branding-and-advertisingHeineken n-v-global-branding-and-advertising
Heineken n-v-global-branding-and-advertising
Gazal Gupta
 
emerging nokia - should they focus on developed or emerging markets
 emerging nokia - should they focus on developed or emerging markets emerging nokia - should they focus on developed or emerging markets
emerging nokia - should they focus on developed or emerging markets
Saurabh Arora
 

What's hot (20)

Case Analysis - HubSpot: Inbound Marketing and Web 2.0
Case Analysis - HubSpot: Inbound Marketing and Web 2.0 Case Analysis - HubSpot: Inbound Marketing and Web 2.0
Case Analysis - HubSpot: Inbound Marketing and Web 2.0
 
Samsung Edge Case Competition 2018 PPT
Samsung Edge Case Competition 2018 PPTSamsung Edge Case Competition 2018 PPT
Samsung Edge Case Competition 2018 PPT
 
Analysis on Kiehl's Marketing & Execution
Analysis on Kiehl's Marketing & ExecutionAnalysis on Kiehl's Marketing & Execution
Analysis on Kiehl's Marketing & Execution
 
Ontella
OntellaOntella
Ontella
 
Netflix Case Study
Netflix Case StudyNetflix Case Study
Netflix Case Study
 
Red Brand Canners
Red Brand CannersRed Brand Canners
Red Brand Canners
 
RED BRAND CANNERS
RED BRAND CANNERSRED BRAND CANNERS
RED BRAND CANNERS
 
Case Study of Marketing the Nissan Micra and Tata Nano
Case Study of Marketing the Nissan Micra and Tata NanoCase Study of Marketing the Nissan Micra and Tata Nano
Case Study of Marketing the Nissan Micra and Tata Nano
 
Old Hand or New Blood Case Study
Old Hand or New Blood Case StudyOld Hand or New Blood Case Study
Old Hand or New Blood Case Study
 
Final hubspot presentation
Final hubspot presentationFinal hubspot presentation
Final hubspot presentation
 
Case Study : Eco7-Launching a New Motor Oil
Case Study : Eco7-Launching a New Motor OilCase Study : Eco7-Launching a New Motor Oil
Case Study : Eco7-Launching a New Motor Oil
 
Frey farms
Frey farmsFrey farms
Frey farms
 
Red brand canners
Red brand cannersRed brand canners
Red brand canners
 
Pepsi Lipton Brisk - Harvard Business Review Case
Pepsi Lipton Brisk - Harvard Business Review CasePepsi Lipton Brisk - Harvard Business Review Case
Pepsi Lipton Brisk - Harvard Business Review Case
 
Heineken n-v-global-branding-and-advertising
Heineken n-v-global-branding-and-advertisingHeineken n-v-global-branding-and-advertising
Heineken n-v-global-branding-and-advertising
 
Bbc v sky
Bbc v skyBbc v sky
Bbc v sky
 
Clean edge razor case study
Clean edge razor case studyClean edge razor case study
Clean edge razor case study
 
emerging nokia - should they focus on developed or emerging markets
 emerging nokia - should they focus on developed or emerging markets emerging nokia - should they focus on developed or emerging markets
emerging nokia - should they focus on developed or emerging markets
 
Chateau Margaux case study
Chateau Margaux case studyChateau Margaux case study
Chateau Margaux case study
 
Business marketing
Business marketingBusiness marketing
Business marketing
 

Viewers also liked

Sweet sensors lecture 7 partners
Sweet sensors lecture 7 partnersSweet sensors lecture 7 partners
Sweet sensors lecture 7 partners
Stanford University
 
Healthy Business Models? A Framework for Business Model Design and How it May...
Healthy Business Models? A Framework for Business Model Design and How it May...Healthy Business Models? A Framework for Business Model Design and How it May...
Healthy Business Models? A Framework for Business Model Design and How it May...
Joost Rietveld
 

Viewers also liked (13)

Sweet sensors lecture 7 partners
Sweet sensors lecture 7 partnersSweet sensors lecture 7 partners
Sweet sensors lecture 7 partners
 
Healthcare Hackathon Business Model Canvas
Healthcare Hackathon Business Model CanvasHealthcare Hackathon Business Model Canvas
Healthcare Hackathon Business Model Canvas
 
Healthy Business Models? A Framework for Business Model Design and How it May...
Healthy Business Models? A Framework for Business Model Design and How it May...Healthy Business Models? A Framework for Business Model Design and How it May...
Healthy Business Models? A Framework for Business Model Design and How it May...
 
Business model canvas healthcare
Business model canvas healthcareBusiness model canvas healthcare
Business model canvas healthcare
 
Business model canvas-Hetero Healthcare Ltd(Pharmaceutical Company)
Business model canvas-Hetero Healthcare Ltd(Pharmaceutical Company)Business model canvas-Hetero Healthcare Ltd(Pharmaceutical Company)
Business model canvas-Hetero Healthcare Ltd(Pharmaceutical Company)
 
Day care facility business model
Day care facility business modelDay care facility business model
Day care facility business model
 
Samsung Case Study
Samsung Case StudySamsung Case Study
Samsung Case Study
 
Canvas examples
Canvas examplesCanvas examples
Canvas examples
 
Venture Design Workshop: Business Model Canvas
Venture Design Workshop: Business Model CanvasVenture Design Workshop: Business Model Canvas
Venture Design Workshop: Business Model Canvas
 
MyMedRecs NYU Final Presentation
MyMedRecs NYU Final PresentationMyMedRecs NYU Final Presentation
MyMedRecs NYU Final Presentation
 
Business Model Canvas 101
Business Model Canvas 101Business Model Canvas 101
Business Model Canvas 101
 
What Is A Business Model
What Is A Business ModelWhat Is A Business Model
What Is A Business Model
 
10 New Business Models for this Decade
10 New Business Models for this Decade10 New Business Models for this Decade
10 New Business Models for this Decade
 

Similar to Sweet sensors lecture 8 resources

Sweet sensors lecture 6 revenue model
Sweet sensors lecture 6 revenue modelSweet sensors lecture 6 revenue model
Sweet sensors lecture 6 revenue model
Stanford University
 
How your vision practice can benefit by offering hearing services
How your vision practice can benefit by offering hearing servicesHow your vision practice can benefit by offering hearing services
How your vision practice can benefit by offering hearing services
OptiCall
 
Sweet sensors lecture 5 cust relationships
Sweet sensors lecture 5 cust relationshipsSweet sensors lecture 5 cust relationships
Sweet sensors lecture 5 cust relationships
Stanford University
 
Biocon Q4FY12_Investor Presentation_April_2012
Biocon Q4FY12_Investor Presentation_April_2012Biocon Q4FY12_Investor Presentation_April_2012
Biocon Q4FY12_Investor Presentation_April_2012
Biocon
 
Inserogen lecture 6 revenue model
Inserogen lecture 6 revenue modelInserogen lecture 6 revenue model
Inserogen lecture 6 revenue model
Stanford University
 
Sweet sensors final presentation
Sweet sensors final presentationSweet sensors final presentation
Sweet sensors final presentation
Stanford University
 
18 phi optics-i-corps-finalpresentation-draft
18   phi optics-i-corps-finalpresentation-draft18   phi optics-i-corps-finalpresentation-draft
18 phi optics-i-corps-finalpresentation-draft
phioptics
 
BCG Overview Of Services And Value Propositions 2010
BCG Overview Of Services And Value Propositions 2010BCG Overview Of Services And Value Propositions 2010
BCG Overview Of Services And Value Propositions 2010
chalverson
 
Future of Market Access – a Pharma Perspective
Future of Market Access – a Pharma PerspectiveFuture of Market Access – a Pharma Perspective
Future of Market Access – a Pharma Perspective
PM Society
 

Similar to Sweet sensors lecture 8 resources (20)

Sweet sensors lecture 6 revenue model
Sweet sensors lecture 6 revenue modelSweet sensors lecture 6 revenue model
Sweet sensors lecture 6 revenue model
 
Affinity NSF Final Presentation
Affinity NSF Final PresentationAffinity NSF Final Presentation
Affinity NSF Final Presentation
 
How your vision practice can benefit by offering hearing services
How your vision practice can benefit by offering hearing servicesHow your vision practice can benefit by offering hearing services
How your vision practice can benefit by offering hearing services
 
Sweet sensors lecture 5 cust relationships
Sweet sensors lecture 5 cust relationshipsSweet sensors lecture 5 cust relationships
Sweet sensors lecture 5 cust relationships
 
Best Practices in Forecasting & Optimization
Best Practices in Forecasting & OptimizationBest Practices in Forecasting & Optimization
Best Practices in Forecasting & Optimization
 
Pharma New Product Planning- Medical Affairs Report Summary
Pharma New Product Planning- Medical Affairs Report SummaryPharma New Product Planning- Medical Affairs Report Summary
Pharma New Product Planning- Medical Affairs Report Summary
 
LighTip NSF FInal Presentation
LighTip NSF FInal PresentationLighTip NSF FInal Presentation
LighTip NSF FInal Presentation
 
Inserogen lecture 7 partners
Inserogen lecture 7 partnersInserogen lecture 7 partners
Inserogen lecture 7 partners
 
CMAC 2011 Presentation
CMAC 2011 PresentationCMAC 2011 Presentation
CMAC 2011 Presentation
 
luxe research presentation at InnoCos Europe, Paris
luxe research presentation at InnoCos Europe, Parisluxe research presentation at InnoCos Europe, Paris
luxe research presentation at InnoCos Europe, Paris
 
Biocon Q4FY12_Investor Presentation_April_2012
Biocon Q4FY12_Investor Presentation_April_2012Biocon Q4FY12_Investor Presentation_April_2012
Biocon Q4FY12_Investor Presentation_April_2012
 
Where Right Brain Meets Left: Translating for Medical and Pharmaceutical Mark...
Where Right Brain Meets Left: Translating for Medical and Pharmaceutical Mark...Where Right Brain Meets Left: Translating for Medical and Pharmaceutical Mark...
Where Right Brain Meets Left: Translating for Medical and Pharmaceutical Mark...
 
Inserogen lecture 6 revenue model
Inserogen lecture 6 revenue modelInserogen lecture 6 revenue model
Inserogen lecture 6 revenue model
 
Sweet sensors final presentation
Sweet sensors final presentationSweet sensors final presentation
Sweet sensors final presentation
 
18 phi optics-i-corps-finalpresentation-draft
18   phi optics-i-corps-finalpresentation-draft18   phi optics-i-corps-finalpresentation-draft
18 phi optics-i-corps-finalpresentation-draft
 
Inserogen lecture 8 resources
Inserogen lecture 8 resourcesInserogen lecture 8 resources
Inserogen lecture 8 resources
 
BCG Overview Of Services And Value Propositions 2010
BCG Overview Of Services And Value Propositions 2010BCG Overview Of Services And Value Propositions 2010
BCG Overview Of Services And Value Propositions 2010
 
Future of Market Access – a Pharma Perspective
Future of Market Access – a Pharma PerspectiveFuture of Market Access – a Pharma Perspective
Future of Market Access – a Pharma Perspective
 
Results of the Apollon pilot in homecare and independent living
Results of the Apollon pilot in homecare and independent livingResults of the Apollon pilot in homecare and independent living
Results of the Apollon pilot in homecare and independent living
 
Agilent Profile
Agilent ProfileAgilent Profile
Agilent Profile
 

More from Stanford University

More from Stanford University (20)

Team Networks - 2022 Technology, Innovation & Great Power Competition
Team Networks  - 2022 Technology, Innovation & Great Power CompetitionTeam Networks  - 2022 Technology, Innovation & Great Power Competition
Team Networks - 2022 Technology, Innovation & Great Power Competition
 
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries  - 2022 Technology, Innovation & Great Power CompetitionTeam LiOn Batteries  - 2022 Technology, Innovation & Great Power Competition
Team LiOn Batteries - 2022 Technology, Innovation & Great Power Competition
 
Team Quantum - 2022 Technology, Innovation & Great Power Competition
Team Quantum  - 2022 Technology, Innovation & Great Power CompetitionTeam Quantum  - 2022 Technology, Innovation & Great Power Competition
Team Quantum - 2022 Technology, Innovation & Great Power Competition
 
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
Team Disinformation  - 2022 Technology, Innovation & Great Power CompetitionTeam Disinformation  - 2022 Technology, Innovation & Great Power Competition
Team Disinformation - 2022 Technology, Innovation & Great Power Competition
 
Team Wargames - 2022 Technology, Innovation & Great Power Competition
Team Wargames  - 2022 Technology, Innovation & Great Power CompetitionTeam Wargames  - 2022 Technology, Innovation & Great Power Competition
Team Wargames - 2022 Technology, Innovation & Great Power Competition
 
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
Team Acquistion  - 2022 Technology, Innovation & Great Power Competition Team Acquistion  - 2022 Technology, Innovation & Great Power Competition
Team Acquistion - 2022 Technology, Innovation & Great Power Competition
 
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition Team Climate Change - 2022 Technology, Innovation & Great Power Competition
Team Climate Change - 2022 Technology, Innovation & Great Power Competition
 
Altuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedAltuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons Learned
 
Invisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons LearnedInvisa Engr245 2022 Lessons Learned
Invisa Engr245 2022 Lessons Learned
 
ānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learnedānanda Engr245 2022 Lessons Learned
ānanda Engr245 2022 Lessons Learned
 
Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef Gordian Knot Center Roundtable w/Depty SecDef
Gordian Knot Center Roundtable w/Depty SecDef
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
 
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
Team Army venture capital - 2021 Technology, Innovation & Great Power Competi...
 
Team Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power CompetitionTeam Catena - 2021 Technology, Innovation & Great Power Competition
Team Catena - 2021 Technology, Innovation & Great Power Competition
 
Team Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power CompetitionTeam Apollo - 2021 Technology, Innovation & Great Power Competition
Team Apollo - 2021 Technology, Innovation & Great Power Competition
 
Team Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power CompetitionTeam Drone - 2021 Technology, Innovation & Great Power Competition
Team Drone - 2021 Technology, Innovation & Great Power Competition
 
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power CompetitionTeam Short Circuit - 2021 Technology, Innovation & Great Power Competition
Team Short Circuit - 2021 Technology, Innovation & Great Power Competition
 
Team Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power CompetitionTeam Aurora - 2021 Technology, Innovation & Great Power Competition
Team Aurora - 2021 Technology, Innovation & Great Power Competition
 
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
Team Conflicted Capital Team - 2021 Technology, Innovation & Great Power Comp...
 
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - CyberLecture 8 - Technology, Innovation and Great Power Competition - Cyber
Lecture 8 - Technology, Innovation and Great Power Competition - Cyber
 

Recently uploaded

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 

Recently uploaded (20)

Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 

Sweet sensors lecture 8 resources

  • 1. Sweet Sensors Small form factor Types of targets diagnostic devices that can detect a variety of • Recreational drugs biological markers. • Heavy metals • Toxins • Inexpensive • Bacteria • Quantitative • Viruses • Adaptable to many • Pharmaceuticals kinds of tests (targets) • Environmental hazards • Food safety targets Yu Xiang and Yi Lu, Nature Chem. 3, 697-703 (2011).
  • 2. Meetings/Conversations From the Past Week • Tecan group – Global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. • Teleconference with Director of Strategic Alliances and three of her associates in a major pharmaceutical company • Abbott • Director of Economic & Technical Development Zone, Shanghai China • Food Safety and Quality Conference • Dr. Bill Olson, Market Medical Director - Pacific Region United Healthcare
  • 3. Upcoming Conversations • Sword Diagnostics • Abbott Labs • Blue Cross Blue Shield innovation team • Retired Hospital executive • Biotech entrepreneur • Michael Rosen, life sciences entrepreneur and executive • Other VCs
  • 4. Key findings: • Big pharma company is interested in low cost drug monitoring during clinical trials and after the drugs are approved to ensure safety and effectiveness of the drug to individual patients – Site visit in December • Work with glucose meter manufacturers – Our technology makes a particular glucose meter more competitive on the market • Look for biomarkers for diseases that associated with diabetes • Invitation to give a presentation @Abbott in December • Emergency room, rapid toxicology screen
  • 5. Business Model Canvas # 8 Yi Lu, Tian Lan, Brian Wong Sweet Sensors Neil Kane 11-15-2011 Chris Sorensen Conferences R&D Pharmaceutical Immediate results Pharmaceutical companies Publicity companies Direct Convenient monitoring Diagnostics Insurance Reimbursement and safer dosage Long term companies Diagnostic Robust/extensible companies Contract research organizations Inexpensive Contract research organizations Simple Pharmaceutical Cos IP Investors Glucometer mfr Personnel Pharmaceutical Cos Strip mfr Licensing Licensing? R&D Product Sales
  • 6. Partners • As noted on the Business Model Canvas, key partners are pharmaceutical companies and glucose meter manufacturers. Sweet Sensors Glucose meter Pharmaceutical / manufacturer • Added value for meter diagnostic companies • Meter engineering manufacturers • Provide the target of • Strip design • Low cost, fast interest • FDA approval monitoring improves • Key customers clinical trials • Key market knowledge
  • 7. Action plan • Put together a compelling presentation and go pitch pharmaceutical companies and diagnostic companies. We’re getting inconclusive results talking to KOLs and consultants. • We are on second revision of a pitch to use.
  • 8. Sweet Sensor Revenue Model Factors COPD MARKET All Segments Market Size 16,000,000 Revenue Model Market Share Target 10% Channel Capacity 100% Customer Activations 1,600,000 Attrition 10% Net Customers 1,440,000 Missing: Revenue Model Usage per Year 52 Lifetime value of customer Number of Uses per Year Revenue per Use $4 74,880,000 $4 and amortization of Total revenue $299,520,000 acquisition costs over EXPENSES Cost Per Customer Acquisition $25 $25 lifetime Cust. Acquisiiton Expense $40,000,000 Channel Split 30% 30% Cost of Channel Sales $89,856,000 COGS $0.25 $18,720,000 Net Operating Income $150,944,000 Operating Margin 50% Operating Expenses GSA $5,000,000 EBIDTA $145,944,000 Net Margin 49%
  • 9. Service Channel Distribution Model Payment Insurance Doctor Company Medical Payment Services Data Service Service Provider Patient “Healthways” In House Care Services Payment Sweet Sensors

Editor's Notes

  1. Team introduction, glucose meter for detection of targets other than glucose; a device/strip to use with a glucometer for detection of non-glucose targets.
  2. the old days of one wonder drug to cure all patients is gone and most pharmaceutical company is facing drugs are safe and effective to only certain populations. Therefore close and daily monitoring of therapeutic drugs is required.